Developer docs
API playgroundTry for free, no card

Search company profiles

Chesapeake Urology

Full company profile

uuid02m29vw

Namestring
Chesapeake Urology
Company typeenum
Private
Founded yearstring
-
Descriptiontext

Chesapeake Urology is a private, multi-specialty urology practice serving patients across Maryland, the Mid-Atlantic region, and southern Delaware. The practice operates through more than 25 office locations and Summit Ambulatory Surgery Centers, treating over 455,000 patients annually with a team of more than 100 urologists, oncologists, interventional radiologists, and advanced providers. Its clinical footprint spans general urology, urologic oncology, surgical urology, urogynecology, male sexual health, radiation oncology, and medical oncology, supported by specialized sub-brands such as The Prostate Center at Quarry Lake, The Continence Center, and the Chesapeake Urology Cancer Center at Towson.

The practice delivers care through a broad procedural toolkit that includes robotic-assisted surgeries (prostatectomy, partial nephrectomy, sacrocolpopexy), laser therapies (GreenLight, HoLEP), focal and ablative technologies (HIFU, Nanoknife, Cryotherapy, Brachytherapy), and minimally invasive BPH treatments (Aquablation, UroLift, Rezum, iTIND). Advanced diagnostics such as MRI fusion prostate biopsy and PET/CT imaging anchor the diagnostic-to-treatment pathway. A dedicated Clinical Research Program has conducted over 200 clinical trials, providing patients access to emerging therapies and giving the practice a research-oriented positioning relative to community urology competitors.

Revenue is generated on a fee-for-service basis through insurance billing, Medicare, and Medicaid, with services covered across most major plans. The practice is led by Dr. Brad D. Lerner as President, with Dr. Geoffrey N. Sklar serving as Chief Medical Officer of United Urology Group, and partners with OneOncology, Summit Ambulatory Surgery Centers, and United Urology Group. Patient acquisition occurs through physician referrals, self-referral, healthcare provider networks, a digital patient portal (FollowMyHealth), telehealth, and patient education content. No public listing, funding rounds, or investor ownership is disclosed.

Short descriptiontext

Chesapeake Urology is a private multi-specialty urology practice operating 25+ locations across Maryland and the Mid-Atlantic region, including southern Delaware, serving 455,000+ patients annually with 100+ specialists in oncology, robotic surgery, and interventional radiology.

Operating statusenum
Operating
Ownership categoryenum
akta.pro rankint
Markets served

Serves global market

Offices21 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
urology care services, urologic oncology treatment, robotic surgery center, interventional radiology, ambulatory surgical facilities
Industry4 codes
1General Urology
CodeHLAKAOAAPrimaryYes
2Urologic Oncology
CodeHLAKAOABPrimaryNo
3Pediatric Urology
CodeHLAKAOAEPrimaryNo
4Reconstructive Urology & Urethral Stricture Care
CodeHLAKAOAHPrimaryNo
NAICS code1 code
  • Offices of Physicians62111
SIC code1 code
  • Services-Offices & Clinics Of Doctors Of Medicine8011
Product category
Urology Healthcare Services
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Healthcare Services Revenue
TypeSubscription Recurring
Description

Fee-for-service healthcare revenue generated from diagnostic procedures, treatments, surgeries, and medical consultations. Services covered through insurance plans, Medicare, and Medicaid. Revenue derived from evaluation and management visits, surgical procedures, diagnostic testing, radiation oncology, medical oncology, and interventional radiology treatments.

chesuro.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D, Others
Pricing details1 tier
1Medical consultation and evaluation services
ModelOtherBilling cadencePay-as-you-go
Notes

Billed through insurance; coverage varies by plan

chesuro.com
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 of 4 records shown
1Summit Ambulatory Surgery Centers
Description

Ambulatory surgery centers operated in partnership with Chesapeake Urology providing surgical care in modern, state-of-the-art facilities

chesuro.com
+3 more records
Core offering1 text field

Chesapeake Urology is a comprehensive urology practice delivering medical, surgical, and oncologic care for urologic conditions across Maryland and the Mid-Atlantic region including southern Delaware. It offers general urology, urologic oncology, surgical urology, interventional radiology, urogynecology, male sexual health, radiation oncology, and medical oncology services, supported by advanced diagnostics, minimally invasive and robotic-assisted procedures, and over 200 clinical trials through its research program.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 455,000+ patients served annually
+2 more records
Product overview1 text field

Chesapeake Urology is a comprehensive urology practice providing integrated urologic care across Maryland and the Mid-Atlantic region including southern Delaware. The practice operates as a multi-service healthcare organization offering general urology, urologic oncology, surgical urology, interventional radiology, urogynecology, male sexual health, radiation oncology, and medical oncology services. The company provides advanced treatments including robotic surgeries (prostatectomy, partial nephrectomy, sacrocolpopexy), laser therapies (GreenLight, HoLEP), focal therapies (HIFU, Nanoknife, Cryotherapy), and minimally invasive BPH treatments (Aquablation, UroLift, Rezum, iTIND). Services are delivered through over 25 locations including Summit Ambulatory Surgery Centers, with a dedicated research program supporting over 200 clinical trials. The practice serves more than 455,000 patients annually with a team of urologists, oncologists, and advanced providers.

Product and service27 records
1General Urology
CategoryGeneral Clinical Service
2Urologic Oncology
CategoryCancer Care
3Surgical Urology
CategorySurgical Service
4Interventional Radiology
CategorySpecialty Procedure
5Urogynecology / Pelvic Medicine & Reconstructive Surgery
CategorySpecialty Clinical Service
6Male Sexual Health
CategorySpecialty Clinical Service
7Radiation Oncology
CategoryCancer Care
8Medical Oncology & Hematology
CategoryCancer Care
9Robotic Prostatectomy
10Robotic Partial Nephrectomy
11Robotic Sacrocolpopexy
12Aquablation Therapy
13GreenLight Laser Therapy
14HIFU (High-Intensity Focused Ultrasound)
15HoLEP (Holmium Laser Enucleation of the Prostate)
16UroLift
17Rezum Water Vapor Therapy
18iTIND (Temporarily Implanted Nitinol Device)
19MRI Fusion Prostate Biopsy
20Transperineal Prostate Biopsy
21PET/CT Imaging
22Cryotherapy
23Nanoknife
24Clinical Trials & Research
25Telehealth
26Pediatric Urology
27Summit Ambulatory Surgery Centers
Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
1Summit Ambulatory Surgery Centers
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership with Summit Ambulatory Surgery Centers provides patients with access to high-quality surgical care in modern, state-of-the-art facilities. This partnership allows Chesapeake Urology physicians to deliver coordinated urologic procedures in settings designed for safety, comfort, and efficiency, improving patient treatment outcomes.

chesuro.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Chesapeake Urology is a partner of OneOncology, a network focused on advancing community oncology care through innovation and collaboration.

Strategic tierModerateTypeStrategic or Co-development Partner
Description

United Urology Group relationship through shared leadership; Dr. Geoffrey N. Sklar serves as Chief Medical Officer of United Urology Group while also practicing at Chesapeake Urology.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeRegional player
Description

Regional health system in the Mid-Atlantic/Northeast with employed urology services and cancer care. Comparable as a regional incumbent competing for similar patients and referrals in overlapping geographies.

TypeDirect peer
Description

PE-backed urology practice consolidation platform partnering with large regional urology groups across the U.S. Comparable in scale, multi-site delivery, subspecialty breadth, and growth-through-acquisition strategy.

TypeDirect peer
Description

Affiliated with U.S. Urology Partners, providing multi-subspecialty urology care including oncology, robotics, and BPH services. Comparable in service line breadth and integrated ASC model.

TypeDirect peer
Description

National urology practice management network that shares leadership with Chesapeake Urology (Dr. Geoffrey Sklar serves as CMO). Operates a similar model of multi-subspecialty urology groups under a shared services platform, making it the most directly comparable peer.

TypeBroad incumbent
Description

Network of community oncology practices where Chesapeake Urology is a partner. Directly relevant given shared patients in urologic oncology, radiation oncology, and medical oncology.

TypeBroad incumbent
Description

Large multi-specialty physician group with significant urology and oncology offerings across the Northeast and Mid-Atlantic. Comparable in multi-specialty integrated delivery, geographic overlap, and oncology partnerships (e.g., CityMD).

TypeBroad incumbent
Description

National multi-specialty health system with a prominent urology institute offering oncology, robotics, and reconstructive care. Comparable as a tertiary competitor and benchmark for advanced urology programs.

TypeDirect peer
Description

Large multi-site urology practice serving Tennessee with subspecialty coverage across oncology, robotics, and female pelvic medicine. Comparable as a regional multi-subspecialty urology group.

TypeBroad incumbent
Description

Academic medical center with a leading urology department in the Baltimore/Mid-Atlantic market. Comparable as a high-acuity competitor for complex oncology, reconstructive, and clinical trial cases.

TypeDirect peer
Description

Multi-location urology group in Michigan offering general urology, oncology, robotic surgery, and men's health. Comparable as a large regional subspecialty urology practice.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles16 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Chesapeake Urology

Urology Healthcare Serviceschesapeakeurology.com

Chesapeake Urology is a private multi-specialty urology practice operating 25+ locations across Maryland and the Mid-Atlantic region, including southern Delaware, serving 455,000+ patients annually with 100+ specialists in oncology, robotic surgery, and interventional radiology.

What Chesapeake Urology does

Chesapeake Urology is a private, multi-specialty urology practice serving patients across Maryland, the Mid-Atlantic region, and southern Delaware. The practice operates through more than 25 office locations and Summit Ambulatory Surgery Centers, treating over 455,000 patients annually with a team of more than 100 urologists, oncologists, interventional radiologists, and advanced providers. Its clinical footprint spans general urology, urologic oncology, surgical urology, urogynecology, male sexual health, radiation oncology, and medical oncology, supported by specialized sub-brands such as The Prostate Center at Quarry Lake, The Continence Center, and the Chesapeake Urology Cancer Center at Towson.

The practice delivers care through a broad procedural toolkit that includes robotic-assisted surgeries (prostatectomy, partial nephrectomy, sacrocolpopexy), laser therapies (GreenLight, HoLEP), focal and ablative technologies (HIFU, Nanoknife, Cryotherapy, Brachytherapy), and minimally invasive BPH treatments (Aquablation, UroLift, Rezum, iTIND). Advanced diagnostics such as MRI fusion prostate biopsy and PET/CT imaging anchor the diagnostic-to-treatment pathway. A dedicated Clinical Research Program has conducted over 200 clinical trials, providing patients access to emerging therapies and giving the practice a research-oriented positioning relative to community urology competitors.

Revenue is generated on a fee-for-service basis through insurance billing, Medicare, and Medicaid, with services covered across most major plans. The practice is led by Dr. Brad D. Lerner as President, with Dr. Geoffrey N. Sklar serving as Chief Medical Officer of United Urology Group, and partners with OneOncology, Summit Ambulatory Surgery Centers, and United Urology Group. Patient acquisition occurs through physician referrals, self-referral, healthcare provider networks, a digital patient portal (FollowMyHealth), telehealth, and patient education content. No public listing, funding rounds, or investor ownership is disclosed.

Chesapeake Urology firmographics

Firmographics
Name
Chesapeake Urology
Website
https://chesapeakeurology.com
Company type
Private
Operating status
Operating
Short description
Chesapeake Urology is a private multi-specialty urology practice operating 25+ locations across Maryland and the Mid-Atlantic region, including southern Delaware, serving 455,000+ patients annually with 100+ specialists in oncology, robotic surgery, and interventional radiology.
Ownership category
akta.pro rank

Chesapeake Urology industry classification

Industry
Product category
Urology Healthcare Services
NAICS
Offices of Physicians (62111)
SIC
Services-Offices & Clinics Of Doctors Of Medicine (8011)
akta.pro primary industry
General Urology (HLAKAOAA)
akta.pro secondary industries
Urologic Oncology (HLAKAOAB), Pediatric Urology (HLAKAOAE), Reconstructive Urology & Urethral Stricture Care (HLAKAOAH)

Keywords

  • Urology care services
  • Urologic oncology treatment
  • Robotic surgery center
  • Interventional radiology
  • Ambulatory surgical facilities

Chesapeake Urology business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D, Others

Revenue model

  1. Healthcare Services Revenue: Fee-for-service healthcare revenue generated from diagnostic procedures, treatments, surgeries, and medical consultations. Services covered through insurance plans, Medicare, and Medicaid. Revenue derived from evaluation and management visits, surgical procedures, diagnostic testing, radiation oncology, medical oncology, and interventional radiology treatments.

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goMedical consultation and evaluation services

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Chesapeake Urology product offering

Product offering

Core offering

Chesapeake Urology is a comprehensive urology practice delivering medical, surgical, and oncologic care for urologic conditions across Maryland and the Mid-Atlantic region including southern Delaware. It offers general urology, urologic oncology, surgical urology, interventional radiology, urogynecology, male sexual health, radiation oncology, and medical oncology services, supported by advanced diagnostics, minimally invasive and robotic-assisted procedures, and over 200 clinical trials through its research program.

Product overview

Chesapeake Urology is a comprehensive urology practice providing integrated urologic care across Maryland and the Mid-Atlantic region including southern Delaware. The practice operates as a multi-service healthcare organization offering general urology, urologic oncology, surgical urology, interventional radiology, urogynecology, male sexual health, radiation oncology, and medical oncology services. The company provides advanced treatments including robotic surgeries (prostatectomy, partial nephrectomy, sacrocolpopexy), laser therapies (GreenLight, HoLEP), focal therapies (HIFU, Nanoknife, Cryotherapy), and minimally invasive BPH treatments (Aquablation, UroLift, Rezum, iTIND). Services are delivered through over 25 locations including Summit Ambulatory Surgery Centers, with a dedicated research program supporting over 200 clinical trials. The practice serves more than 455,000 patients annually with a team of urologists, oncologists, and advanced providers.

Differentiator

Problem solved

Functional benefit

Brands

  • Summit Ambulatory Surgery Centers: Ambulatory surgery centers operated in partnership with Chesapeake Urology providing surgical care in modern, state-of-the-art facilities
  • The Continence Center
  • The Prostate Center at Quarry Lake
  • Chesapeake Urology Cancer Center at Towson

Products and services

  • General Urology
  • Urologic Oncology
  • Surgical Urology
  • Interventional Radiology
  • Urogynecology / Pelvic Medicine & Reconstructive Surgery
  • Male Sexual Health
  • Radiation Oncology
  • Medical Oncology & Hematology
  • Robotic Prostatectomy
  • Robotic Partial Nephrectomy
  • Robotic Sacrocolpopexy
  • Aquablation Therapy
  • GreenLight Laser Therapy
  • HIFU (High-Intensity Focused Ultrasound)
  • HoLEP (Holmium Laser Enucleation of the Prostate)
  • UroLift
  • Rezum Water Vapor Therapy
  • iTIND (Temporarily Implanted Nitinol Device)
  • MRI Fusion Prostate Biopsy
  • Transperineal Prostate Biopsy
  • PET/CT Imaging
  • Cryotherapy
  • Nanoknife
  • Clinical Trials & Research
  • Telehealth
  • Pediatric Urology
  • Summit Ambulatory Surgery Centers

Quantifiable outcome

  • 455,000+ patients served annually
  • +2 more outcomes

Companies that use Chesapeake Urology

Customer profile

Named customers1 record

Segments1 record

Ideal customer profiles2 records

Chesapeake Urology technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Chesapeake Urology partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and moderate.

  • Summit Ambulatory Surgery CenterscoreStrategic or Co-development PartnerPartnership with Summit Ambulatory Surgery Centers provides patients with access to high-quality surgical care in modern, state-of-the-art facilities. This partnership allows Chesapeake Urology physicians to deliver coordinated urologic procedures in settings designed for safety, comfort, and efficiency, improving patient treatment outcomes.
  • OneOncologycoreStrategic or Co-development PartnerChesapeake Urology is a partner of OneOncology, a network focused on advancing community oncology care through innovation and collaboration.
  • United Urology GroupmoderateStrategic or Co-development PartnerUnited Urology Group relationship through shared leadership; Dr. Geoffrey N. Sklar serves as Chief Medical Officer of United Urology Group while also practicing at Chesapeake Urology.

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Chesapeake Urology competitors and assessment

Company assessment

Regional players

  • Atlantic Health System: Regional health system in the Mid-Atlantic/Northeast with employed urology services and cancer care. Comparable as a regional incumbent competing for similar patients and referrals in overlapping geographies.

Direct peers

  • U.S. Urology Partners: PE-backed urology practice consolidation platform partnering with large regional urology groups across the U.S. Comparable in scale, multi-site delivery, subspecialty breadth, and growth-through-acquisition strategy.
  • Arizona Urology Specialists: Affiliated with U.S. Urology Partners, providing multi-subspecialty urology care including oncology, robotics, and BPH services. Comparable in service line breadth and integrated ASC model.
  • United Urology Group: National urology practice management network that shares leadership with Chesapeake Urology (Dr. Geoffrey Sklar serves as CMO). Operates a similar model of multi-subspecialty urology groups under a shared services platform, making it the most directly comparable peer.
  • Tennessee Urology Associates: Large multi-site urology practice serving Tennessee with subspecialty coverage across oncology, robotics, and female pelvic medicine. Comparable as a regional multi-subspecialty urology group.
  • Michigan Institute of Urology: Multi-location urology group in Michigan offering general urology, oncology, robotic surgery, and men's health. Comparable as a large regional subspecialty urology practice.

Broad incumbents

  • OneOncology: Network of community oncology practices where Chesapeake Urology is a partner. Directly relevant given shared patients in urologic oncology, radiation oncology, and medical oncology.
  • Summit Health: Large multi-specialty physician group with significant urology and oncology offerings across the Northeast and Mid-Atlantic. Comparable in multi-specialty integrated delivery, geographic overlap, and oncology partnerships (e.g., CityMD).
  • Cleveland Clinic: National multi-specialty health system with a prominent urology institute offering oncology, robotics, and reconstructive care. Comparable as a tertiary competitor and benchmark for advanced urology programs.
  • Johns Hopkins Medicine: Academic medical center with a leading urology department in the Baltimore/Mid-Atlantic market. Comparable as a high-acuity competitor for complex oncology, reconstructive, and clinical trial cases.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Chesapeake Urology social profiles

Digital presence

Chesapeake Urology financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Chesapeake Urology leadership team

Management profile

Number of profiles

Profiles16 records

Chesapeake Urology funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Chesapeake Urology M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Chesapeake Urology

What does Chesapeake Urology do?

Chesapeake Urology is a comprehensive urology practice delivering medical, surgical, and oncologic care for urologic conditions across Maryland and the Mid-Atlantic region including southern Delaware. It offers general urology, urologic oncology, surgical urology, interventional radiology, urogynecology, male sexual health, radiation oncology, and medical oncology services, supported by advanced diagnostics, minimally invasive and robotic-assisted procedures, and over 200 clinical trials through its research program.

Is Chesapeake Urology a public or private company?

Chesapeake Urology is a private company. It is classified as unknown and is currently operating.

When was Chesapeake Urology founded?

Chesapeake Urology was founded in -1.

How does Chesapeake Urology make money?

One revenue line is on record: healthcare Services Revenue.

Who are Chesapeake Urology's main competitors?

Atlantic Health System is listed as a regional player. Direct peers are U.S. Urology Partners, Arizona Urology Specialists, United Urology Group, Tennessee Urology Associates and Michigan Institute of Urology. Broad incumbents are OneOncology, Summit Health, Cleveland Clinic and Johns Hopkins Medicine.

Does Chesapeake Urology have an API?

No public API is recorded for Chesapeake Urology.

What industry is Chesapeake Urology in?

Chesapeake Urology's product category is Urology Healthcare Services. Its primary akta.pro industry code is HLAKAOAA, General Urology, with a secondary code of HLAKAOAB, Urologic Oncology. Its NAICS code is 62111 and its SIC code is 8011.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireChesapeake Urology and Northwest Hospital First in Maryland to Offer Aquablation Therapy for the Treatment of Benign Prostatic Hyperplasia (BPH)Chesapeake Urology physician Dr. Andrew Harbin performed the first Aquablation procedure in Maryland at Northwest Hospital in Randallstown on December 9, 2021. The procedure utilizes a heat-free, robotic-controlled waterjet to precisely remove obstructive prostate tissue for the treatment of benign prostatic hyperplasia, offering symptom relief with reduced sexual side effects compared to traditional surgical methods.PR NewswireChesapeake Urology Treats First Patient in Maryland in the OASIS Clinical Trial for Overactive BladderChesapeake Urology has treated the first patient in Maryland for the OASIS clinical trial evaluating the RENOVA iStim system, an investigational neurostimulation implant developed by BlueWind Medical for overactive bladder. The device is designed to reduce urinary urge leakage through a minimally invasive outpatient procedure and home-based therapy, aiming to address limitations of current treatments. This enrollment marks progress in a multi-center study involving approximately 200 subjects across Europe and the U.S., with results intended to support a future FDA submission.PR NewswireChesapeake Urology Welcomes Three New Physicians, Expanding Specialty Services in Anne Arundel, Howard, and Montgomery Counties and Baltimore CityChesapeake Urology, an affiliate of United Urology Group, recently welcomed three new physicians—David A. Levy, M.D., Devang Sharma, M.D., and Katherine Smentkowski, M.D.—expanding its roster of specialists across Maryland. Dr. Levy brings expertise in prostate cryosurgery and prostate cancer nutrition, Dr. Sharma specializes in male infertility and sexual dysfunction, and Dr. Smentkowski focuses on bladder and kidney cancer, kidney stones, and robotic surgery. The additions extend Chesapeake Urology's specialty services into Anne Arundel, Howard, and Montgomery Counties and Baltimore City, with the company now operating 24 medical offices and 17 ambulatory surgery centers.PR NewswireRichard M. Levin, M.D., F.A.C.S., C.P.I., Surpasses 375 Rezūm Treatments for BPH, Making Him One of Top Rezūm Physicians in U.S.Dr. Richard M. Levin of Chesapeake Urology has surpassed 375 Rezūm Water Vapor Therapy procedures for treating benign prostatic hyperplasia, making him one of the top Rezūm physicians in the United States and the first in the Northeast and Mid-Atlantic region to achieve Center of Excellence designation in January 2020. He played a leading role in the Rezūm II clinical study that led to the system's FDA approval in September 2015 and is now enrolling patients in Francis Medical's VAPOR 1 clinical study evaluating water vapor ablation for prostate cancer treatment.PR NewswireStopping Urinary Leakage with a Novel Hydrogel and No Surgery - Bulkamid® Therapy for Stress Urinary Incontinence in Women is a GamechangerChesapeake Urology is offering Bulkamid therapy, a non-invasive hydrogel injection treatment for stress urinary incontinence that was recently approved by the FDA in the United States. The procedure, which has been used successfully in Europe for over 15 years, involves injecting a water-based gel to seal the urethra and prevent urine leakage with little to no downtime for patients.PR NewswireChesapeake Urology Welcomes Three New Physicians, Expanding Specialty Services in Baltimore and Montgomery Counties and Baltimore CityChesapeake Urology, an affiliate of United Urology Group, announced the addition of three fellowship-trained physicians to its practice, expanding specialty services in Maryland and Delaware. The new hires — Laura L. Giusto, Melissa Mendez, and Alan L. Kaplan — bring expertise in female pelvic medicine, reconstructive surgery, and sexual dysfunction. The expansion reinforces Chesapeake Urology's presence across 24 offices and 18 ambulatory surgery centers in the region.PR Newswire"This Year, It's Personal"Dr. Sanford J. Siegel, Chairman of Chesapeake Urology, is using his personal battle with advanced prostate cancer to promote the 12th Annual ZERO Prostate Cancer Run/Walk Baltimore scheduled for September 23, 2018. The event aims to raise $1 million to fund free screenings, research, and patient assistance programs through its non-profit partner, ZERO-The End of Prostate Cancer. Chesapeake Urology has a long-standing history of supporting these initiatives, having provided over 9,000 free screenings and raised more than $4 million since 2006.PR NewswireTubeless PCNL Is One Of The Most Effective, Innovative Surgical Techniques For Removing Large, Complex Kidney StonesTubeless percutaneous nephrolithotomy (PCNL) is an effective minimally invasive surgical technique for removing large kidney stones that cannot be treated with common or non-surgical methods, and is becoming a preferred alternative to more invasive procedures. Two surgeons at Chesapeake Urology have collectively performed over 1,000 tubeless PCNL procedures since 2015, using a hemostatic plug developed by Dr. Julio Davalos that eliminates the need for a post-operative nephrostomy tube. Chesapeake Urology, a fully-integrated urology practice operating 25 medical offices and 17 ambulatory surgery centers across Maryland counties, is highlighting this technique as a breakthrough offering reduced pain and faster recovery for patients.GlobeNewswireHIFU for Prostate Cancer Now Available at Chesapeake UrologyHIFU Prostate Services partnered with Chesapeake Urology to offer HIFU treatment for localized prostate cancer in the Mid-Atlantic region. The non-invasive procedure uses focused ultrasound to destroy prostate tissue, reducing side effects, and a Medicare code may help cover costs. The one-time outpatient procedure allows patients to return home the same day.PR Newswire25 Chesapeake Urology and Urological Consultants Physicians Named "Top Doctors" for 2017Twenty-five physicians from Chesapeake Urology and its Urological Consultants division were recognized as "Top Doctors" for 2017 in Baltimore and Washingtonian magazine's annual peer-nominated listings. The physicians were selected through surveys of over 25,000 regional doctors who were asked to name doctors they would send their own family members to for care. Chesapeake Urology operates 25 medical offices and 17 ambulatory surgery centers across Maryland counties with over 87 physicians on staff.